The potent protein phosphatase 2A inhibitors aminocytostatins: new derivatives of cytostatin.
Shigehiro TohyamaManabu KawadaHideyuki MuramatsuMasaki HatanoHiroyuki InoueKazuaki MatobaRyuichi SawaMasayuki IgarashiPublished in: The Journal of antibiotics (2021)
Specific inhibitors of protein phosphatase 2A (PP2A) mediate anticancer effects by augmenting the tumor-killing activity of natural killer (NK) cells. In this study, new PP2A inhibitors, aminocytostatins A-E, were isolated from Kitasatospora sp. MJ654-NF4 and structurally characterized. Aminocytostatins are derivatives of cytostatin, which is a specific PP2A inhibitor isolated from the same organism, and aminocytostatins have a characteristic amino group within the lactone moiety. Compared to cytostatin, aminocytostatin A showed a stronger inhibitory activity against PP2A in vitro and augmented the tumor-killing activity of NK cells in vivo. Furthermore, a docking model was generated to demonstrate the favorable activities of aminocytostatin A.